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Abstract: Geoffroea decorticans is a xerophilous deciduous tree present in most arid forests of southern
South America, which is commonly used in traditional medicine. The seeds of this tree have been
previously investigated for their singular chemical composition, but their protein content has been
poorly investigated. Herein, we report the isolation, purification, and characterization of a set of
thermostable peptides derived from Geoffroea decorticans seeds (GdAPs) with strong antioxidant and
anticoagulant activities. The most potent antioxidant peptides showed a half maximal inhibitory
concentration (IC50) of 35.5 ± 0.3 µg/mL determined by 1,1-diphenyl-2-picrylhydrazyl (DPPH).
They also caused a dose-dependent prolongation of the aPTT clotting time with an IC50 value of
~82 µg/mL. Interestingly, MALDI-TOF/MS analysis showed the presence of three major peptides
with low molecular weights of 2257.199 Da, 2717.165 Da, and 5422.002 Da. The derived amino-acid
sequence of GdAPs revealed their unique structural features, exhibiting homology with various
proteins present in the genome of Arachis hypogaea. All in all, our data suggest a direct applicability
of GdAPs for pharmaceutical purposes.
Keywords: Geoffroea decorticans; antioxidant; functional compound; thermostable protein; reactive
oxygen species; anticoagulant; bioactive compound
1. Introduction
Over many centuries, plants have historically made a major contribution to phar-
macology. In fact, an important number of currently available drugs are derived directly
or indirectly from natural products, especially as antibacterial or antitumor agents [1,2].
However, there is growing evidence that modern pharmacology has only explored and vali-
dated a small part of this large array of molecular entities. The best-characterized examples
of bioactive molecules derived from plants include peptides, proteins, sugars, nucleo-
sides, or products of the secondary metabolism of the plant. Among them, plant-derived
peptides have shown a variety of interesting biological activities such as hypertensive, hy-
poglycemic, antioxidant, and/or anticoagulant properties. This broad bioactivity spectrum
of these peptide molecules makes them attractive for the treatment or prevention of various
diseases [3–5].
In recent years, substantial research efforts were dedicated toward the discovery of
novel drugs to treat cardiovascular diseases (CVDs). CVDs are a group of disorders of the
heart and blood vessels that represent one of the major causes of mortality worldwide. In
most cases, the drugs used to treat CVDs are anticoagulant molecules that inhibit or delay
coagulation by acting on one or more coagulation factors. Coagulation and fibrinolysis are
interrelated enzymatic processes that, together with mechanisms involving the vascular
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wall and platelets, keep the blood flowing within the blood vessels. An inadequate activa-
tion of coagulation or the uncontrolled activation of fibrinolysis can generate hemorrhagic
disorders, such as in Von Willebrand’s disease, hemophilia, or hemolytic anemia [6]. It is
known that a cascade of enzyme activations occurs in the coagulation process, which are
mainly regulated by inhibitors of a protein nature [7]. Current pharmacological agents
used to prevent or treat thrombotic disorders are mostly synthetic antiplatelet, anticoag-
ulants, and fibrinolytic agents [8], which remain under continuous review due to their
adverse effects and bleeding risks [9,10]. Thus, the identification of novel anticoagulant
compounds from natural sources has gained interest because of their direct application
in the treatment of CVDs and other associated diseases such as viral infections [11], can-
cer [12], malaria [13], hypertension [14,15], and/or blood disorders [16]. On the other hand,
it has been previously demonstrated that reactive oxygen species (ROS) play a vital role
in the development and progression of CVDs [17–21]. In fact, generation of ROS and free
radicals have deleterious effects on many molecules in the human body, such as DNA, fatty
acids, and proteins [22]. Typically, proteins and peptides can inhibit oxidative reactions,
in part due to their ability in neutralizing the effects of transition metals, leading to the
formation of less reactive insoluble metal complexes [23]. Recent studies have shown that
crude proteins from some of the seeds of plant species such as pea [24], chickpea [25],
and peanut kernels [26] display strong antioxidant activity associated with a low toxicity
profiles [27].
A growing number of bioactive peptides have been identified from various medicinal
plant sources [28–31]. Geoffroea decorticans (Gill. ex Hook. et Arn.) Burkart (Fabaceae) is a
xerophilous deciduous tree mostly found in arid areas of South America used in traditional
medicine. This plant is also known commonly as chañar. Chañar fruits have been con-
sumed fresh or cooked by human communities since ancient times [32,33]. The fruits of G.
decorticans are brown spherical drupes with sweet pulp and palatable taste. The edible part
is composed of the fleshy mesocarp that, air-dried, contains 11.10% sugars and 4.49% resins
with 8.75% protein, 15.20% reducing sugar, and 52.89% starch and other carbohydrates.
Chañar seeds are also edible (both fresh or roasted) with about 22% protein and a high
oil content of about 47%, where the oleic–linoleic ratio stands out (53.7%:30.7%) [34]. In
addition, some studies have reported antifungal properties in the organic extracts of the
chañar stem bark, especially associated with inflammatory processes [35–38]. Despite all
these previous studies, the protein composition and activity of the bioactive compounds
present in this plant have been poorly characterized.
Herein, we report the isolation and characterization of a set of thermostable bioactive
peptides obtained from G. decorticans seeds. These native peptides showed a potent
antioxidant activity in vitro. Furthermore, we demonstrate the suitability of these bioactive
peptides as anticoagulant molecules targeting the intrinsic pathway of coagulation. Taken
together, the current results provide useful information for the production of novel plant-
derived anticoagulant molecules with additional functionalities.
2. Materials and Methods
2.1. Materials
2.1.1. Chemicals
Coomassie Blue G-250, sodium chloride, tris(hydroxymethyl) aminomethane, sodium
dodecyl sulfate (SDS), N,N,N0,N0-tetramethylethylenediamine (TEMED), β-mercaptoethanol
(βME), 1,1-diphenyl-2-picrylhydrazyl (DPPH), bovine serum albumin (BSA) and 2,20-azino-
bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) were purchased from
Sigma-Aldrich (Saint Louis, MO, USA). Glyoxyl-agarose was purchased from FlukaTM
(Charlotte, NC, USA).
2.1.2. Sample Collection
The ripe fruits of Geoffroea decorticans were hand-collected from 20 trees located in the
department of Juan Martín de Pueyrredón (33◦16002.90 0 S 66◦12050.20 0 W), Juana Koslay,
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San Luis province, Argentina. The samples were collected in January 2018 and identified
as Geoffroea decorticans (Gill., ex Hook & Arn, Burkart, family Fabacea) by specialists of the
Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Argentina.
A voucher specimen was deposited at the Herbarium of the Universidad Nacional de San
Luis (UNSL Del Vitto N◦ 553). G. decorticans fruits were flash-frozen and stored at −20 ◦C
until use.
2.2. Crude Extract Preparation and Determination of the Protein Content
Chañar seeds were obtained from G. decorticans (chañar) fruits after the woody en-
docarp was hand-broken and removed. To prepare the crude extract, 10 g of seeds were
washed with distilled water. The sample was ground using a blender in 100 mL of 0.1 M
Tris–HCl buffer, pH 7.5. This process was performed on an ice bath to reduce protein
denaturation. After incubation for 120 min at 4 ◦C, the mixture was filtered through a fine
screen cloth and centrifuged for 30 min at 7000× g at 4 ◦C. Afterward, the supernatant
(hereafter GdCE) was collected and immediately flash-frozen at −20 ◦C.
The soluble protein was determined using Bradford’s assay [39]. Briefly, to perform
the reactions, 10 µL of each standard solution or test sample was mixed with 200 µL of
the Bradford reagent. After 10 min incubation at room temperature, the absorbance at
595 nm was recorded using a Tecan Infinite M200 PRO spectrophotometer (Männedorf,
Switzerland). Bovine serum albumin (BSA) was used as a protein concentration standard.
This method is particularly suitable for the determination of protein content of vegetable
extracts, which usually have phenolic compounds that interfere with the traditional Lowry
method. All the measurements of the soluble protein content were carried out in triplicate.
2.3. Purification of Antioxidant Peptides
2.3.1. Initial Purification by Heat Treatment
The crude extract (GdCE) was subjected to a water bath at 90 ◦C for 30 min. After
cooling the sample, precipitated proteins were removed by centrifugation at 4 ◦C for 30 min
at 7000× g. After centrifugation, the soluble protein content and the antioxidant activity of
the nontreated crude extract and the heat-treated sample (GdHT) were determined. SDS-
PAGE analysis was used to determine the protein profile during the different purification
steps. Gels were silver-stained following the Chevallet, Luche, and Rabilloud [40] protocol.
Densitograms for each lane were produced using the GelAnalyzer 19.1 program. The
obtained peaks were compared according to computed Rf (Retardation factor) values and
band intensity, which is proportional to the protein concentration on each peak.
2.3.2. Size-Exclusion Chromatography
A 1 mL aliquot of the heat-treated sample (1767 µg/mL) was loaded onto a Sephacryl-
S100 HR column (1.5 × 40 cm) connected to an Äkta-Purifier (GE Healthcare) previously
equilibrated with milliQ water. Elution was carried out using an isocratic gradient and a
flow rate of 0.8 mL/min. During elution, the absorbance was continuously monitored at
280 and 215 nm. The antioxidant activity was determined for each fraction, and the fraction
with the higher antioxidant activity was selected for further analysis.
2.4. MALDI-TOF Mass Spectrometric Analysis
To perform mass spectrometry (MS) analysis, an aliquot of the sample from the
exclusion chromatography was desalted by dialysis in 0.022 µm filters. The dialyzed sample
was mixed with an equal volume of 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic
acid) matrix solution. Then, the matrix–sample mixture was spotted onto an MTP 384
target plate (polished steel TF, Bruker Daltonics, Billerica, MA, USA). After the spots were
evaporated to dryness at room temperature, the mass spectra were acquired on a Bruker
Daltonics Ultraflex MALDI-TOF mass spectrometer (Bruker Daltonics) operating in linear
positive and reflector mode.
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The PMF analysis was performed for identification of the antioxidant peptides of
Chañar. First, an in situ tryptic digestion of the Tris–tricine SDS-PAGE electrophoresis lane
containing the protein bands was performed by following a standard PMF protocol [41]. In
brief, the tryptic peptides were dissolved in 10 µL of 0.1% CF3CO2H (v/v) and analyzed
by MALDI-TOF in the presence of an HCCA matrix. Mass spectra of the tryptic peptides
were acquired using a Bruker Daltonics Ultraflex MALDI-TOF mass spectrometer (Bruker
Daltonics) in a reflectron positive mode operating at 25 kV acceleration voltage. In both
cases, a standard peptide calibration mixture from Bruker Daltonics used as reference.
Four precursor ions MH+ (1267.672, 1682.694, 1925.806, and 2778.353) were subjected to
TOF–TOF fragmentation. The resultant fragmentation spectra for these precursor MH+
ions were compared with all the fragmentation patterns for all the sequences present in the
MASCOT database, considering the carbamidomethylation of all Cys (www.matrixscience.
com, access on 1 April 2020). All the MS experiments were performed at the Proteomics
Core Facility CEQUIBIEM, at the University of Buenos Aires/CONICET (National Research
Council).
2.5. Antioxidant Activity Evaluation
2.5.1. DPPH Radical-Scavenging Activity
The Brand-Williams method was used to evaluate the DPPH scavenging activity
against free radicals [42]. The method was adapted to a 96-well flat-bottom plate. In
essence, 50 µL of each sample were mixed with 50 µL of a 0.2 mmol/L DPPH radical
solution and 150 µL of methanol. After incubation for 20 min at 37 ◦C in dark conditions,
the absorbance of each well was measured at 517 nm using a microplate spectrophotometer.
As a control condition, the maximum DPPH absorbance was determined by replacing
the sample volume with the same volume of water. For IC50 determination, six different
concentrations for each sample were analyzed. Measurements were carried out in triplicate.
The IC50 values were calculated using GraphPad software. DPPH radical-scavenging
activity was calculated using the following equation:
DPPH radical scavenging activity (%) = 100 × A1 − A2
A1
,
where A1 is the absorbance of the control without sample and A2 is the absorbance in
presence of sample and DPPH.
2.5.2. ABTS Radical-Scavenging Activity
The ABTS+ radical-scavenging activity was determined using the method described
by Pukalskas et al. [43], with slight modifications. The antioxidant activity in the samples
was analyzed by adding 10 µL of sample to 190 µL of diluted ABTS+ solution. After 10 min
incubation at room temperature in the darkness, absorbance at 734 nm was measured using
a microplate spectrophotometer. Measurements were carried out in triplicate. For IC50
determination, six different concentrations of each sample were analyzed. All the assays
were carried out in triplicate. The IC50 values were calculated using GraphPad software.
The ABTS+ radical-scavenging activity was calculated using the following equation:
ABTS radical scavenging activity (%) = 100 − 100 × A1 − A2
A0
,
where A0 is the absorbance of the control without sample and A1 is the absorbance in the
presence of the sample and ABTS+. A2 corresponds to the value of absorbance of sample
blank without ABTS+.
2.6. Anticoagulant Activity
The anticoagulant activity of GdAPs was evaluated as previously described by our
group [44]. In essence, we measured the prothrombin time (PT) and the time of activated
partial thromboplastin (aPTT) using a Coatron M1 coagulometer (TECO, Germany). Before
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performing the experiments, a pool of blood plasmas obtained from five different samples
of healthy individuals was prepared, aliquoted, and stored at 37 ◦C with 3.8% sodium
citrate (sample–anticoagulant ratio of 9:1). This reference sample was used in both determi-
nations (hereafter PBP) to evaluate the PT and aPTT time. For the PT test, the commercial
Soluplastin reactive was used (Wiener Lab.) To perform reactions, equal parts of the sample
PBP and GdAPs (0–215 µg/mL) were incubated for 2 min at 37 ◦C. Afterward, 50 µL of
Soluplastin were added to 25 µL of the mixture and the sample was evaluated in order to
determine the coagulation time. For the aPTT test, 25 µL of aPTT (Wiener Lab.) was added
to an equal volume of PBP–GdAPs mixture (previously incubated for 2 min at 37 ◦C). After
incubation for 2 min at 37 ◦C, 25 µL of 50 mM CaCl2 was added to the samples. All the
experiments were performed at least in triplicate.
2.7. Statistical Analysis
Statistical analyses (ANOVA) were performed using GraphPad Prism v. 01 soft-
ware (http://www.graphpad.com/scientific-software/prism/, access on 10 June 2021). A
Tukey’s post hoc test (p < 0.05) was used to identify significant differences between the
means of the different groups analyzed.
3. Results and Discussion
3.1. Isolation and Purification of the Antioxidant Peptides
A crude extract (GdCE), with a protein concentration of 1069 µg/mL, was obtained
from chañar seeds. As a second step of purification, the crude extract was subjected to a
heat treatment (hereafter referred to as GdHT), which had a lower protein concentration
than the crude extract (489 µg/mL). Figure 1A shows the purification and densitogram
analysis of the electrophoretic profile of the proteins present in the crude extract and the
heat-treated sample. In essence, this analysis revealed that the thermal treatment produces
a removal of heat-labile proteins, with molecular masses over 20 kDa, according to the
concentration values obtained by the Bradford assay. Thus, the incubation of the crude
extract at high temperatures generated a clarified product that was more suitable for the
next purification steps, where there was a higher proportion of low-molecular-weight
proteins than in the crude extract. It is worth mentioning that heat treatment does not affect
the stability of low-molecular-weight proteins, as previously reported for plant protease
inhibitors that preserve their biological activity after thermal treatments [4,5].
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Figure 1. Isolation and purification of antioxidant pe ti es fr eoffroea ecortica s see s. (A) Densitogram of SDS-
tricine-PAGE of the crude extract of Geoffroea decorticans (GdCE, dotted line) and the heat-treated sample (GdHT, solid line).
(B) Size-exclusion chromatography elution profile of the Geoffroea decorticans heat-treated sample. Fractions 1–4 selected for
posterior analysis are shown between dotted lines.
Next, we aimed to evaluate the antioxidant capacity of the crude extract and the
heat-treated sample in order to monitor the presence of peptides with antioxidant activity
in both fractions. This initial analysis showed that the IC50 values for GdHT (IC50 by
DPPH = 63.2 ± 0.6 µg/mL; IC50 by ABTS = 141.3 ± 3.1 µg/mL) were lower than those
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obtained for GdCE (IC50 by DPPH = 82.5 ± 1.3 µg/mL; IC50 by ABTS = 175.7 ± 4.5 µg/mL).
Subsequently, 1 mL of GdHT in 1767 µg/mL concentration was loaded into a size-exclusion
column, and the eluted fractions were monitored by absorbance at 280 nm. As shown in
Figure 1B, the initial sample was separated into four different fractions. A detailed analysis
of this profile revealed a predominance of a fraction that eluted with a retention volume
close to 60 mL, corresponding to low-molecular-weight proteins. Then, we determined
the antioxidant activity on 20 µg/mL of the four fractions obtained by size-exclusion
chromatography (see Figure 2). In this way, it was possible to identify the presence of
peptides with a strong antioxidant activity in fractions 2, 3, and 4. However, the major
activity was found in fraction 3 (see Figure 2). Typically, low-molecular-weight peptides
are related to a greater antioxidant capacity [45–48]. However, in this case, fraction 3 had
higher antioxidant activity compared to fraction 4. This difference could be attributed to the
singular peptide composition of each fraction. Furthermore, it was possible to appreciate
differences between the antioxidant activities obtained by the ABTS method with respect to
that observed for DPPH. These differences, which were also observed in the crude and the
heat-treated extracts, can be explained by the difference in the diffusivity of the radicals in
the reaction medium; while ABTS radicals are soluble in both organic solvents and aqueous
solutions, DPPH radicals are only soluble in organic medium [49]. Accordingly, fraction 3
(from now on GdAPs) was selected for the following biochemical analyses.
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1– ere se t t e s e c ce tr ti . * 0.05, co pare t ABTS control reactions (control) without sample.
3.2. Identification and Antioxidant Properties of GdAPs
The protein fraction with the highest antioxidant activity was ubjected to MALDI-
TOF mas spectrometry analysis (see ti f etails). As shown in Figure 3, the
MS spectra r vealed the pr sence of three predomi ant low-molecular-weight peaks with
a parent molecular masses of 2257.199 Da, 2717.165 Da, and 5422.002 Da (see Figure 3).
This result indicates that fraction 3 is enriched in a set of peptides in the range of 2–8 kDa,
with a predominance of three major peptide species. In order to identify the antioxidant
peptides present in the sample, the bands corresponding to the three major peptides
observed on the SDS-PAGE were submitted to tryptic digestion. The resulting peptides
mixture obtained by tryptic digestion was evaluated by MALDI-TOF–TOF MS/MS in
order to determine their amino-acid sequences. From these analyses it was possible
to solve the sequence of four different tryptic peptides corresponding to (a) a 1267.672
Da peptide: EHIMPLGQNGR, (b) a peptide of 1682.694 Da: QPSPQDYLNAHNAAR,
(c) a 1925.806 Da peptide: YGENIAWSSGDLSGTAAVK, and (d) a 2778.353 Da peptide:
SEVGVPNLPWDDTVAAYAQNYANQR. When the amino-acid sequence of peptide (a)
was compared to NCBI’s nonredundant database, no similarity was found with any of the
peptide sequences deposited in the database. For sequences (b), (c), and (d), the database
identified them with several hypothetical proteins from other plants of the Fabaceae
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family (see Table S1). The sequence alignment between the sequences deposited in the
database and the peptides (b), (c), and (d), shows that these three peptides correspond to
various regions found in hypothetical proteins obtained from the Arachis hypogaea genome
(Figure 3). These proteins arise from the sequencing of the complete genome of the plant
of origin and represent proteins predicted on the basis of the genomic sequence, without
having been isolated, purified, and/or characterized so far. Therefore, this result is in
agreement with the presence of newly discovered bioactive molecules in G. decorticans that
have not been previously characterized.
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i t t t on their antioxidant activity [50]. It is com on to find a high repr sentation
of amino acids such as His, Trp, Phe, Pro, Gly, lys, Ile, and Val in ti i t ti s.
eir resi es are endorsed with intrinsic radical-scavenging activity in oxidative reactions,
especially for those enzyme-catalyzed reactions. I the case of Trp, the presence of an
imidazole ring is an important chemical feature [51]. Another study also suggested that
the antioxidant capacity of peptides could be notably enhanced by the overrepresentation
of three aro atic a ino acids such as Trp, Tyr, and Pre [52]. In addition, the indole and
pyrrolidine rings present in Trp and Pro, respectively, could also serve as good hydroxyl
radical scavengers. Other amino acids, i.e., Gly, Lys, Ile, and Val, may be responsible for
creating a favorable hydrophobic environment for peptide molecules. As observed from
the partial amino-acid sequence obtained for GdAPs, the four identified peptides exhibited
hydrophobic amino acids in their sequence, in accordance with the amino-acid composition
that is characteristic for antioxidant peptides [50–52]. Lastly, considering the relevance for
the biomedical field on the description of novel natural antioxidant molecules, a detailed
characterization of the antioxidant capacity of GdAPs was carried out by determining the
concentration IC50 values of these peptides. Again, we used both ABTS and DPPH methods
to determine the antioxidant activity of the peptides at five different concentrations (see
Figure 4). The resultant IC50 values were 95.1 ± 0.6 µg/mL and 35.5 ± 0.3 µg/mL for the
ABTS and DPPH methods, respectively (see Figure 4). These values are in the range of the
IC50 values of other antioxidant peptides derived from natural origin [28–31]. Furthermore,
the results of the IC50 obtained for GdAPs with respect to the values for GdHT show that
they decreased by half for both methods, which is consistent with the purification obtained
by means of molecular exclusion chromatography (see Table 1).
Pharmaceutics 2021, 13, 1153 8 of 12
Pharmaceutics 2021, 13, x FOR PEER REVIEW 8 of 13 
 
 
the range of the IC50 values of other antioxidant peptides derived from natural origin [28–
31]. Furthermore, the results of the IC50 obtained for GdAPs with respect to the values for 
GdHT show that they decreased by half for both methods, which is consistent with the 
purification obtained by means of molecular exclusion chromatography (see Table 1). 





Inhibition of DPPH 
IC50 (µg/mL) 
Purification Fold (a) 





Crude extract 21.4 ± 0.4 100 82.5 ± 1.2 1 175.7 ± 3.1 1 
90 °C heat treatment 17.7 ± 0.5 82.6 ± 0.7 63.2 ± 0.8 1.3 ± 0.1 141.3 ± 2.7 1.2 ± 0.1 
Size-exclusion 
chromatography 
3.1 ± 0.2 14.1 ± 0.3 35.5 ± 0.5 2.3 ± 0.1 95.1 ± 0.9 1.9 ± 0.1 
(a) Purification fold determined for DPPH inhibition; (b) purification fold determined for ABTS inhibition. 
The purification methodologies used here yielded 14.1% and a 2.3 and 1.9 purifica-
tion fold when analyzed by DPPH and ABTS, respectively, similar to the purification fold 
observed in previous studies [53]. Therefore, the production of antioxidant peptides from 
chañar seeds is potentially feasible to be scaled at an industrial level, since it does not 
require large investment or very extensive technological processes. Most of the antioxi-
dant peptides reported to date correspond to peptides generated by enzymatic hydrolysis 
[45,48]. However, purifying native antioxidant peptides may have several advantages in 
comparison with the obtention of peptides produced by enzymatic hydrolysis. These ad-
vantages include the presence of low levels of allergens or the absence of bitter taste in the 
final product(s) [54,55]. The major antioxidant peptides present in G. decorticans are not 
only within the lower range of molecular weight obtained for other peptides, but also 
have a greater antioxidant capacity than other native peptides/proteins reported to date, 
such as GSQ [28], G4b [53], QCZDE, QCZCM [56], TCP-III [31], and APC [29] (Table 2). 
 
 
Figure 4. Antioxidant activity of Geoffroea decorticans antioxidant peptides. (A) DPPH radical-scavenging activity. (B) ABTS 
radical-scavenging activity. The vertical bars correspond to the standard deviation of three independent measurements (n 
= 3). 
  
Figure 4. Antioxidant activity of Geoffroea decorticans antioxi tides. (A) DPPH radical-scavenging activity. (B) ABTS
radical-scavenging activity. The vertical bars correspond to the standard deviation of three independent measurements
(n = 3).
Table 1. Purification steps and antioxidant activity of GdAPs from Geoffroea decorticans seeds.











Crude extract 21.4 ± 0.4 100 82.5 ± 1.2 1 175.7 ± 3.1 1
90 ◦C heat treatment 17.7 ± 0.5 82.6 ± 0.7 63.2 ± 0.8 1.3 ± 0.1 141.3 ± 2.7 1.2 ± 0.1
Size-exclusion chromatography 3.1 ± 0.2 14.1 ± 0.3 35.5 ± 0.5 2.3 ± 0.1 95.1 ± 0.9 1.9 ± 0.1
(a) Purification fold determined for DPPH inhibition; (b) purification fold determined for ABTS inhibition.
The purification methodologies used here yielded 14.1% and a 2.3 and 1.9 purifi-
cation fold when analyzed by DPPH and ABTS, respectively, similar to the purification
fold observed in previous studies [53]. Therefore, the production of antioxidant pep-
tides from chañar seeds is potentially feasible to be scaled at an industrial level, since
it does not require large investment or very extensive technological processes. Most of
the antioxidant peptides reported to date correspond to peptides generated by enzymatic
hydrolysis [45,48]. However, purifying native antioxidant peptides may have several ad-
vantages in comparison with the obtention of peptides produced by enzymatic hydrolysis.
These advantages include the presence of low levels of allergens or the absence of bitter
taste in the final product(s) [54,55]. The major antioxidant peptides present in G. decorticans
are not only within the lower range of molecular weight obtained for other peptides, but
also have a greater antioxidant capacity than other native peptides/proteins reported
to date, such as GSQ [28], G4b [53], QCZDE, QCZCM [56], TCP-III [31], and APC [29]
(Table 2).
Table 2. Native antioxidant peptides/proteins isolated from plant sources in the last decade.
Antioxidant Peptide/Protein Plant Source MW (Da) IC50 by DPPH(µg/mL)
IC50 by ABTS
(µg/mL) References
GSQ Allium tuberosum Rottler 290.10 610 40 [28]
G4b Ginkgo biloba seeds 29,247 100.7 n/d [53]
QCZDE Apium graveolens seeds 6500 n/d 158.7 [56]
QCZCM Apium graveolens seeds 11,390 n/d 193.2 [56]
Gg-AOPI Gnetum gnemon seeds 30,000 21 10 [30]




Rhizomes 18,000 n/d n/d [57]
PNP Phyllanthus nuri leaves 35,000 n/d n/d [58]
TCP-III Terminalia chebula fruit 16,267 291 n/d [31]
APC Murraya koenigii leaves 35,000 70 n/d [29]
GdAPs Geoffrea decorticans 2000–8000 35.5 95.1 -
Abbreviations: n/d, not determined.
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3.3. GdAPs Display Strong Anticoagulant Activiy against the Intrinsic Pathway
The diseases associated with the blood circulation system are the main causes of
mortality in many countries all over the world [59]. In this context, anticoagulants such as
heparin, coumarine, or warfarin have been widely used for the treatment of arterial and
venous thrombotic disorders, as well as in preventive medicine. However, these common
anticoagulant drugs present some limitations such as their inefficacy in antithrombin-
deficient patients, bleeding complications, and/or the potential development of drug-
induced thrombocytopenia and immunosuppression. The presence of these complications
has prompted scientists to exploit natural products as a solid alternative to currently
available anticoagulants [60].
Herein, we assessed the activity of the purified GdAPs in an activated partial throm-
boplastin time (aPTT) assay. Using this approach, we evaluated the activation of the
intrinsic and common pathways of the coagulation cascade as the time taken for fibrin
clot formation. As shown in Figure 5A, the purified GdAPs caused a prolongation of the
clotting time in a dose-dependent manner. An important key parameter that is drawn from
this in vitro assay is the dose of the anticoagulant that provides two-fold prolongation of
clotting time compared with the untreated samples. This allows measuring the effect of our
peptides against factors VIII, IX, XI, and XII and Prekallikrein of the coagulation cascade.
GdAPs showed a twofold prolongation time at concentrations in the range 86–215 µg/mL,
with an IC50 value of ~82 µg/mL (see Figure 5B). Interestingly, the prothrombin time (PT)
was not significantly increased in the presence of GdAPs in the range of concentrations
assayed (IC50 > 215 µg/mL). As a comparison, heparin, a drug commonly used in clinical
applications, in a concentration of 2 mg·mL−1, produces a delay in coagulation time for
the aPTT route from 18 to 300 s [61], while GdAPs produces the same effect at much lower
concentrations of 172 µg·mL−1. This behavior was previously reported for other peptides
from plant origin such as the trypsin inhibitors from Leucaena leucocephala [62], Enterolobium
contortisiliquum [63], and Maclura pomifera [64].
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In summary, the presented results show that GdAPs have significant beneficial effects
as an anticoagulant drug. In addition, our results demonstrate that these peptides target the
intrinsic pathway, leading to a retardation of the clotting time. Taken together, our results
encourage future studies on the mechanism of action of GdAPs and the development of
in vivo assays that could be promising for a potential exploitation of these peptides as
naturally occurring antioxidant and antithrombotic agents.
4. Conclusions
Plants represent a rich source of bioactive compounds suitable for pharmaceutical
applications. Although G. decorticans is a native plant endemic of South America that is
Pharmaceutics 2021, 13, 1153 10 of 12
recognized for its medicinal properties, only few reports of bioactive molecules isolated
from this plant source are available so far [44]. In this study, we successfully isolated a set
of native peptides present in G. decorticans seeds. To achieve this, the seed extracts were
subjected to simple purification steps, such as heat treatment and molecular exclusion
chromatography. Other previous reports used enzymatic hydrolysis with proteases as
biocatalysts, which requires multiple time-consuming steps and additional reagents for the
production of the bioactive peptides. Interestingly enough, these peptides have remarkable
thermal stability, which is an added benefit of their conservation without the need for
refrigeration. This would allow their use to be adapted to many geographical regions of
the world that have a shortage of technologies and adequate infrastructure for storage.
Lastly, we demonstrated that the peptides present in G. decorticans have a strong antioxidant
capacity, comparable to other previously isolated molecules (see Table 2). More interestingly,
we revealed that such molecules have a strong anticoagulant effect against the intrinsic
coagulation pathway. All in all, our findings position G. decorticans as an attractive source
of bioactive molecules and suggest a possible biomedical application of GdAPs isolated
from the seeds of this plant.
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